Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Drugs
- Pharmaceuticals
- Therapeutic
- Cancer
- Disease
- Immune
- Vaccine
- Dermatology
- Antibody
- cardiac
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 26785
The licensee is a U.S. company.
The term carbohydrate embraces a wide variety of chemical compounds having the general formula (CH.sub.2 O).sub.n, such as monosaccharides, disaccharides, oligosaccharides and polysaccharides. Oligosaccharides are chains composed of saccharide units, which are alternatively known as sugars. These saccharide units can be arranged in any order and the linkage between two saccharide units can occur in any of approximately ten different ways. As a result, the number of different possible stereoisomeric oligosaccharide chains is enormous.
U.S. Patent No. 5,180,674, entitled Saccharide Compositions, Methods and Apparatus for their Synthesis, issued January 19, 1993.
U.S. Patent No. 5,288,637, entitled Apparatus for the Synthesis of Saccharide Compositions, issued February 22, 1994.
U.S. Patent No. 5,583,042, entitled Apparatus for the Synthesis of Saccharide Compositions, issued December 10, 1996.
U.S. Patent No. 5,874,261, entitled Method for the Purification of Glycosyltransferases, issued February 23, 1999.
U.S. Patent No. 6,156,547, entitled Apparatus for the Synthesis of Saccharide Compositions, issued December 5, 2000.
U.S. Patent No. 6,331,418, entitled Saccharide Compositions, Methods and Apparatus for Their Synthesis, issued December 18, 2001.
U.S. Patent No. 6,518,051, entitled Saccharide Compositions, Methods and Apparatus for Their Synthesis, issued February 11, 2003.
IPSCIO Record ID: 209507
Any license under this Agreement is subject to the DOEs non-exclusive, license for federal government purposes only, and DOEs option to grant licenses for its purposes.
Licensor also grants to Licensee the right to issue fee-bearing sublicenses only in the Field of Use to make and have made, use and have used, offer and have offered for sale, sell and have sold, and import and have imported Licensed Products, so long as Licensee has current exclusive rights in its Field of Use.
Upon expiration, but not earlier termination, of this Agreement, Licensee shall have a non-exclusive, worldwide right to use any information contained or described in the Licensed Patents and any information acquired by Licensee.
Glycoconjugates is the general classification for carbohydrates covalently linked with other chemical species such as proteins, peptides, lipids and saccharides. Glycoconjugates are formed in processes termed glycosylation.
In either case, the Field of Use specifically excludes application of Licensed Patents to sale of reagents for life sciences research purposes, the Excluded Field.
The Broader Field means the synthesis, production or modification of sugars and glycoconjugates in or on biological molecules for research, development and commercialization of human therapeutic applications.
The Specific Applications Field means the synthesis, production or modification of sugars and glycoconjugates in or on biological molecules for research, development and commercialization of human therapeutic applications solely within the three specific therapeutic applications that are negotiated by the parties. The three specific areas will be chosen from the following
Hematology and thrombosis therapies
Oncology therapies
Antibody therapies, including human and humanized antibodies and antibody equivalents
Neurologic, CNS and psycho therapies
Immunology therapies
Infectious disease therapies including vaccines
Cardiovascular therapies
Respiratory therapies
Metabolic disease and condition therapies
Dermatology therapies
Fertility and contraceptive therapies
Imaging agents for use as diagnostics and in connection with therapeutic applications
And any other field upon which the parties may mutually agree.
IPSCIO Record ID: 4311
The License Agreement provides the Licensee with a non-transferable, worldwide license to use the Licensor's VAST technology, including related patents, patent applications and know-how.
The license is exclusive except in relation to one family of patents in respect of which there is an existing non-exclusive third party license.
Under the Technology License Agreement, the Licensee is subject to development obligations, reporting obligations, sublicense revenue sharing requirements, royalty payments and other obligations.
In that regard, the license agreement does not permit the Licensee to sub-license any of the VAST technology without the Licensor's prior consent.
Trade Mark VAST & Chemoform
Patent
Oligosaccharide Synthesis
6,573,337 & 6,723,843
Protected Aminosugars
6,462,183
Protecting and Linking Groups for Organic Synthesis 6,765,089
Protecting Groups for Carbohydrate Synthesis
6,953,850
Combinatorial Libraries of Monosaccharide’s
7,417,129 & 8,093,227
Delivery Systems
7,312,194
Synthetic Heparin Pentasaccharides
7,541,445 & 8,114,970
IPSCIO Record ID: 26973
STATES PATENT [19] [11] PATENT NUMBER 5,506,210 – Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
4,935,406 – Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
IPSCIO Record ID: 2978
Patents and Patent Applications
County Official No. Titla Case Status
Australia 702500 Preparation and Use of Sulfated Oligosaccharides
Registered
Brazil PI9608041-8 Sulfated Oligosaccharide, Process for the
Anti-Angiogenic, Anti-Metastatic and/or Anti-Inflammatory Treatment of a Human Patient or Other Warm/Blooded Animal Patient, use of an Oligosaccharide and Pharmaceutical or Veterinary Composition for Anti-Angiogenesis Pending
Canada 2218872 Preparation and Use of Sulfated Oligosaccharides
Registered
China ZL96193563.4 Preparation and Use of Sulfated Oligosaccharides Registered
Europe 96910861.2 Preparation and Use of Sulfated Oligosaccharides Pending
Israel 118047 Sulfated Oligosaccharides, Pharmaceutical Compositions Containing Them and Preparation of Sulfated Hexopyranose Homooligosaccharides Registered
Japan 532038/96 Preparation and Use of Sulfated Oligosaccharides Pending
Republic of Korea 0591960 Preparation and Use of Sulfated Oligosaccharides Registered
Mexico 243061 Preparation and use of Sulfated Oligosaccharides
Registered
New Zealand 305815 Preparation and Use of Sulfated Oligosaccharides Registered
Poland 184357 Preparation and Use of Sulfated Oligosaccharides
Registered
Russian Federation 001199 Preparation and Use of Sulfated
Registered
Singapore 48558 Preparation and Use of Sulfated Oligosaccharides Registered
Taiwan 138332 Preparation and Use of Sulfated Oligosaccharides
Registered
United States of America 6143730 Preparation and Use of Sulfated Oligosaccharides Registered
South Africa 96/3339 Preparation and Use of Sulfated Oligosaccharides Registered
